Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy

Details for Australian Patent Application No. 2002301344 (hide)

Owner Transgene S.A. Association Francais contre les Myopathies

Inventors Braun, Serge

Agent Freehills

Pub. Number AU-B-2002301344

Parent 40373

Filing date 7 October 2002

Wipo publication date 6 March 2003

Acceptance publication date 13 January 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002301344

13 January 2005 Application Accepted

  Published as AU-B-2002301344

12 May 2005 Standard Patent Sealed

11 January 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301345-Mobile wireless communication handset with sound mixer and methods therefor

2002301343-Rongeur with drainage